FDA Brief

Company record

Cosmo Bio Co., Ltd.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Cosmo Bio Co., Ltd..

Warning letters

  1. Cosmo Bio Co., Ltd.

    FDA cited South Korea's Cosmo Bio for CGMP failures and for selling an unapproved, misbranded acne drug serum in the U.S.

    High risk